Infection Imaging In Nuclear Medicine: Arguing The Case for PET/CT.

Similar documents
SPECT and PET (CT) Imaging in Vascular Graft Infection

SPECT and PET (CT) Imaging in Vascular Graft Infection

INFECTION & INFLAMMATION IMAGING

The Painful Prosthetic Joint: Role of Nuclear Medicine

Nuclear medicine and Prosthetic Joint Infections

04/03/2013. Second Annual BIR SPECT/CT Symposium London, UK 25/02/2013. NMD: Al-Jahra Hospital. NMD: Al-Jahra Hospital

Evaluation of Infection/Inflammation: What is the Role of PET/CT?

Radionuclide Imaging of Infection & Inflammation

Apport de la TEP au FDG dans les infections cardiovasculaires François Rouzet, MD, PhD

18F-FDG PET-CT IMAGING IN INFECTION AND INFLAMMATION

Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography / computed tomography in fever of unknown origin

Imaging of white blood cells with Scintimun

Leucocytscintigraphy. Lene Rørdam Senior Consultant DMSci Department of Clinical Physiology and Nuclear Medicine Bispebjerg University Hospital

New Visions in PET: Surgical Decision Making and PET/CT

Dr Sneha Shah Tata Memorial Hospital, Mumbai.

Deppen S, et al. Annals of Thoracic Surgery 2011;92:

Division of Vascular and Endovascular Surgery University of South Florida School of Medicine Tampa, Florida

FDG PET/CT STAGING OF LUNG CANCER. Dr Shakher Ramdave

OSTEOMYELITIS. If it occurs in adults, then the axial skeleton is the usual site.

PET-MRI in malignant bone tumours. Lars Stegger Department of Nuclear Medicine University Hospital Münster, Germany

PET/CT in lung cancer

NUCLEAR MEDICINE IMAGING IN FUO

Lymphoma Read with the experts

Gallium-67 Citrate in a Patient with Fever of Unknown Origin

Clinical cases and pitfalls using FDG-PET. François Jamar Université Catholique de Louvain, Brussels, Belgium

Pediatric Lymphoma Update from the Children s Oncology Group

FDG-PET/CT in Gynaecologic Cancers

Esophageal Cancer. What is the value of performing PET scan routinely for staging of esophageal cancers

8/10/2016. PET/CT for Tumor Response. Staging and restaging Early treatment response evaluation Guiding biopsy

Short summary of published results of PET with fluoromethylcholine (18F) in prostate cancer

PET-imaging: when can it be used to direct lymphoma treatment?

Management of graft infection after EVAR-TEVAR. Can PET-CT predict the outcome of prosthetic graft infections?

Bone PET/MRI : Diagnostic yield in bone metastases and malignant primitive bone tumors

Positron Emission Tomography in Lung Cancer

Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin s Lymphomas (NHL)

PET and SPECT in Osteomyelitis and Prosthetic Bone and Joint Infections: A Systematic Review

SPECT CT in the Evaluation of Musculoskeletal Disease

The Use of PET Scanning in Urologic Oncology

PRECISION IMAGING: QUANTITATIVE, MOLECULAR AND IMAGE-GUIDED TECHNOLOGIES

L hyperfixation dans le suivi des lymphomes représente-t-elle toujours une maladie active?

Complex Fractures and Hip Dislocations

Whole Body MRI. Dr. Nina Tunariu. Prostate Cancer recurrence, progression and restaging

PET/CT in Gynaecological Cancers. Stroobants Sigrid, MD, PhD Departement of Nuclear Medicine University Hospital,Antwerp

Applications of PET/CT in Rheumatology. Role of PET/CT. Annibale Versari, MD Nuclear Medicine PET Center S.Maria Nuova Hospital Reggio Emilia Italy

Division of Vascular and Endovascular Surgery University of South Florida School of Medicine Tampa, Florida

Performance of the conformable GORE TAG device in Type B aortic dissection from the GORE GREAT real world registry

FLUCICLOVINE: 1 ST FDA APPROVED F-18 PET IMAGING AGENT FOR RECURRENT PROSTATE CANCER

Endocardites infectieuses Des recommandations à la pratique Quelles explorations en 2017?

PET/CT for Therapy Assessment in Oncology

ROLE OF PET-CT IN BREAST CANCER, GUIDELINES AND BEYOND. Prof Jamshed B. Bomanji Institute of Nuclear Medicine UCL Hospitals London

Nuclear Sciences and Medicine

Diagnostic strategy. Dr Pilar Tornos Hospital Vall d Hebron Barcelona

Abdominal and thoracic aneurysm repair

University of Groningen

Radionuclide detection of sentinel lymph node

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

Using Nuclear Medicine Imaging Wisely in Diagnosing Infectious Diseases

Title:Giant cell arteritis exclusively detected by 18F-fluorodeoxyglucose positron emission tomography: a case report

European evidence-based consensus on the use of imaging techniques in inflammatory bowel disease diagnosis and management

PET/CT Frequently Asked Questions

PSEUDO-CELLULITIS - ALL THAT S RED IS NOT INFECTION

Utility of PET-CT for detection of N2 or N3 nodal mestastases in the mediastinum in patients with non-small cell lung cancer (NSCLC)

Case Conference: SBRT for spinal metastases D A N I E L S I M P S O N M D 3 / 2 7 / 1 2

When do you need PET/CT or MRI in early breast cancer?

Screening for and Assessment of Osteonecrosis in Oncology Patients. Sue C. Kaste, DO SPR Postgraduate Course 2015

Nuclear Medicine in the Diabetic Foot

Vertebral and Paravertebral Diseases

Using PET/CT in Prostate Cancer

1 Introduction. 2 Materials and methods. LI Na 1 LI Yaming 1,* YANG Chunming 2 LI Xuena 1 YIN Yafu 1 ZHOU Jiumao 1

Follow-up investigations. Omgo E. Nieweg

PET/MR:Techniques, Indications and Applications

Clinical indications for positron emission tomography

APPROPRIATE USE GUIDELINES

Update in Lymphoma Imaging

Neck Imaging Reporting and Data System: An Atlas of NI-RADS Categories for Head and Neck Cancer

PATHWAY #4 DIABETIC FOOT DISORDERS VOLUME 45, NUMBER 5, SEPTEMBER/OCTOBER 2006 S 29

University of Groningen. Nuclear medicine imaging of posttraumatic osteomyelitis Govaert, G. A. M.; Glaudemans, Andor W.J.M.

Interim PET Hodgkin s Disease. Fellows talk Fellow: Shweta Jain Faculty: Ajay Gopal

Radiological staging of lung cancer. Shukri Loutfi,MD,FRCR Consultant Thoracic Radiologist KAMC-Riyadh

FIRST COAST SERVICE OPTIONS FLORIDA MEDICARE PART B LOCAL COVERAGE DETERMINATION

PET CT for Staging Lung Cancer

Treatment of infection

Lugano classification: Role of PET-CT in lymphoma follow-up

Bone and Joint Infections in Diabetics: Diagnosis and Management of Diabetic Foot and Other Common Lower Extremity Infections

4th INTERNATIONAL WORKSHOP ON INTERIM-PET IN LYMPHOMA Palais de l Europe, Menton Oct 4-5, 2012

American College of Radiology ACR Appropriateness Criteria Imaging After Total Knee Arthroplasty

Case 37 Clinical Presentation

Challenges. 1. Sizing. 2. Proximal landing zone 3. Distal landing zone 4. Access vessels 5. Spinal cord ischemia 6. Endoleak

PARATHYROID NUCLEAR MEDICINE IMAGING REVIEW DISCLOSURES

Subject: PET Scan With or Without CT Attenuation. Original Effective Date: 11/7/2017. Policy Number: MCR: 610. Revision Date(s): Review Date:

SELF-ASSESSMENT MODULE REFERENCE SPR 2018 Oncologic Imaging Course Adrenal Tumors November 10, :00 12:10 p.m.

Staging: Recommendations for bone marrow investigations

MRI-PET: Oncologic Applications

Osteomieliti STEOMIE

Lancashire and South Cumbria Haematology NSSG Guidelines for Follicular Lymphoma:

Los Angeles Radiological Society 62 nd Annual Midwinter Radiology Conference January 31, 2010

Integrating FDG PET data for lymphoma management. Michel Meignan, France

Quantitative Nuclear Medicine Imaging in Oncology. Susan E. Sharp, MD

Novel Imaging in Advanced Prostate Cancer

Staging and restaging for distant metastatic disease in breast cancer: Has anything changed?

Transcription:

Infection Imaging In Nuclear Medicine: Arguing The Case for PET/CT. LUIS A. TAMARA M.D. NUCLEAR MEDICINE /PET-CT SERVICE CHIEF MEDVAMC

DISCLOSURES. 2

3

Not difficult to appreciate the difference! GA-67 CITRATE / LABELED LEUKOCYTES FDG PET-CT 4

So what exactly do you mean? GA-67 / WBC S. FDG PET CT o Use of blood products. o Results available in days. o Relatively low sensitivity and spatial resolution. No blood products required. Results available in a couple of hours. All imaging advantages of PET /CT 5

Fever of Unknown Origin/ Bacteremia of Unknown Source. Low specificity of FDG an advantage. Greater than 90% accuracy. Helpful clinically even when negative. Whole Body scanning routine. Keidar et al. 6

Spinal cord injury patient with persistent fever despite broad, prolonged antimicrobial Rx. 7

Persistent MSSA bacteremia despite adequate treatment of septic joints. 8

Pt with fever and bacteremia. 9

61 y. o. male with polymicrobial bacteremia of unknown source Patent rt. PV Lt. PV Thrombus Patent rt. PV Lt. PV Thrombosis 10

61 y. o. male with polymicrobial bacteremia of unknown source 11

12

Pt with persistent bacteremia of unknown source 13

Post contrast enhancement Enhancement 14

Acute Osteomyelitis In a lesion-based analysis FDG PET/CT was TP in 18 sites, TN in 26 sites and FP in 2 sites, resulting in a sensitivity, specificity, PPV, NPV and accuracy of 100%, 93%,90 %, 100 % and 96 %, respectively. o Kagna et al. Able to differentiate from neuroarthropathic changes in the diabetic foot. o Basu et al. 15

Pt with bilateral LE cellulitis. 16

Pt with suspected calcaneal osteomyelitis 17

18

Pt evaluated for diabetic foot 19

71 y. o. male on HD with MRSA bacteremia and suspected right hallux osteomyelitis. 20

Same Patient FDG NaF 21

Chronic Osteomyelitis The overall accuracy of FDG PET was 97% with a high degree of inter-observer concordance (x = 0.93). The overall sensitivity and specificity were 100% and 92%, respectively. Guhlman et al. Very high NPV for vertebral osteomyelitis. In certain cases of smoldering chronic osteomyelitis FDG + NaF A little more on that later 22

Vertebral Osteomyelitis 23

Vertebral Osteomyelitis Post Rx 24

Spinal Cord injury patient with decubitus ulcer NaF-FDG 25

SCI patient with decubitus ulcer NaF- FDG 26

Pt with diabetic heel ulcer NaF-FDG 27

Endocarditis and endovascular infections The validity values for the efficacy of PET/CT in the diagnosis of septic lesions were as follows: sensitivity, 100%; specificity, 80%; positive predictive value, 90%; and negative predictive value, 100%. PET/CT was the only initially positive imaging technique in 15 true-positive cases (55.5%). The systematic use of PET/CT was associated with a 2-fold reduction in the number of relapses (9.6% vs. 4.2%, P 5 0.25) and enabled significantly more infectious complications to be diagnosed (18% vs. 57.4%, P 5 0.0001). Kestler et al. 28

69 y. o. male with hx of endocarditis 29

Post Rx. 30

Vascular Graft Infections PET/CT had a sensitivity of 93%, specificity of 91%,positive predictive value of 88%, and negative predictive value of 96% for the diagnosis of vascular graft infection. Keidar et al. Some caveats: Gore Tex (polytetrafluoroethylene) and Dacron. Aseptic inflammation. Wassellius et al. 31

59 y. o. male s/p open heart surgery who presents with MSSA bacteremia. 32

Same patient 33

Post Rx. 34

Non Infectious FDG uptake 35

Labeled Leukocytes. 36

65 y. o. male s/p BLE bypass graft and persistent MRSA bacteremia. 37

The Infected Prosthesis Very high Negative Predictive Value. Specificity not as high due to osteolysis with loosening as well as infection. Non infectious FDG adhesion. In-111-WBC/SC Marrow imaging usually our first choice. 38

Infected and non-infected arthroplasties. 39

40

Pt s/p comminuted distal femoral fracture and suspected infection. 41

Post Rx. 42

Pt s/p excisional biopsy of lymph node. Dx= Lymphoma. 43

Pt returns later and is febrile. Lymphoma recurrence? 44

Patient with recent spinal hardware placement and rising inflammatory markers. Infection is suspected.

SCI patient with unexplained leukocytosis. 47

CONCLUSIONS PET/ CT is a fast, accurate, sensitive and specific diagnostic modality for the majority of infectious indications. It is superior to other NM modalities. It is cost effective. It improves patient care and patient outcomes. Broader CMS coverage would be in the best interest of both patients and managing clinicians. 48

The highest goal of knowledge is service. Kirpal Singh 49

REFERENCES 1. Keidar Z et al. Fever of Unknown Origin: The Role of F18-FDG PET/CT, J Nucl Med 2008; 49:1980 1985. 2. Kagna O et al. FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot, Eur J Nucl Med Mol Imaging (2012) 39:1545 1550. 3. Basu S et al. Potential role of FDG PET in the setting of diabetic neuroosteoarthropathy: can it differentiate uncomplicated Charcot s neuroarthropathy from osteomyelitis and soft-tissue infection? Nuclear Medicine Communications 2007, 28:465 472. 4. Guhlman A et al. Chronic Osteomyelitis: Detection with FDG PET and Correlation with Histopathologic Findings. Radiology #{149} March 1998.

REFERENCES 5. Kestler M et al. Role of 18F-FDG PET in Patients with Infectious Endocarditis, J Nucl Med 2014; 55:1093 1098. 6. Keidar Z et al. Prosthetic Vascular Graft Infection: The Role of 18F-FDG PET/CT, J Nucl Med 2007; 48:1230 1236. 7. Wasselius J et al. High 18F-FDG Uptake in Synthetic Aortic Vascular Grafts on PET/CT in Symptomatic and Asymptomatic Patients, J Nucl Med 2008; 49:1601 1605. 51

CME QUESTIONS 1. In the setting of FUO, PET CT results can be available in a matter of: a. Seconds. b. Minutes. c. Hours. (Key) d. Days. ours Reference 1. 52

2. According to the study quoted in the presentation, FDG PET CT for acute osteomyelitis had a sensitivity of: a. 80 % b. 100 % (key). c. 50 % d. 25 % Reference 2 53

3. The Negative Predictive Value (NPV) of FDG PET CT for vertebral osteomyelitis is: a. Very high (key). b. Very low. c. Unknown. d. Irrelevant. Reference 4. 54

4. According to the study quoted in the presentation, use of FDG PET CT in the setting of endocarditis was associated with a fold reduction in relapse rates. a. 3. b. 5 c. 2 (key). d. 6 Reference 5 55

5. The frequent, low level, diffuse FDG uptake seen in Gore- Tex synthetic vascular grafts is generally considered to reflect: a. Graft failure. b. Graft infection. c. Aseptic inflammation (key). d. Graft thrombosis. Reference 6 56